Published in Am J Hematol on February 01, 2001
The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS One (2010) 0.86
Therapy of autoimmune bullous diseases. Ther Clin Risk Manag (2007) 0.77
Paraneoplastic pemphigus: a short review. Clin Cosmet Investig Dermatol (2016) 0.75
Biologics in dermatology: an integrated review. Indian J Dermatol (2014) 0.75
Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med (1998) 3.21
Focal dermal hypoplasia syndrome in a male patient. Report of a case and histologic and immunohistochemical studies. Arch Dermatol (1992) 2.45
Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet (1998) 1.82
The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol (1997) 1.63
Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180. J Cell Biol (1998) 1.58
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol (2001) 1.54
Vitiligo associated with lichen planus. Is there a pathogenetic relationship? Dermatology (1996) 1.48
[Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology]. Schweiz Med Wochenschr (1997) 1.46
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer (2006) 1.41
Primary liver carcinoma in two sisters with acute intermittent porphyria. Am J Med (1990) 1.41
Treatment of basal cell carcinoma with surgical excision and perilesional interferon-α. J Plast Reconstr Aesthet Surg (2013) 1.38
Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol (1998) 1.30
Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc Natl Acad Sci U S A (1996) 1.25
Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Cancer Care (Engl) (2009) 1.20
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol (2005) 1.20
Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. J Invest Dermatol (1998) 1.16
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol (2001) 1.10
Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry (2001) 1.10
Intraepidermal bullous haemorrhage during anticoagulation with low-molecular-weight heparin: two cases. Br J Dermatol (2009) 1.09
Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Oncogene (2008) 1.08
Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol (1993) 1.07
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer. Dermatology (2010) 1.07
MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem Biophys Res Commun (1987) 1.05
Multiple cutaneous osteomas of the face associated with chronic inflammatory acne. J Eur Acad Dermatol Venereol (2006) 1.03
Takayasu arteritis and cutaneous necrotizing vasculitis. Dermatology (2000) 1.03
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Papular elastorrhexis. report of five cases. Dermatology (2002) 0.99
Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemia. Cancer Genet Cytogenet (1999) 0.98
ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class. Hum Mol Genet (1999) 0.98
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol (2000) 0.97
The subcellular distribution of the high molecular mass protein, HD1, is determined by the cytoplasmic domain of the integrin beta 4 subunit. J Cell Sci (1997) 0.97
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol (2009) 0.96
Schönlein-Henoch purpura associated with losartan treatment and presence of antineutrophil cytoplasmic antibodies of x specificity. Br J Dermatol (2001) 0.95
Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. J Invest Dermatol (1993) 0.94
The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. J Biol Chem (2001) 0.93
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial. Br J Cancer (2004) 0.93
The type I interferon system is locally activated in psoriatic lesions. J Interferon Res (1994) 0.92
Barriers and facilitators to chemotherapy patients' engagement in medical error prevention. Ann Oncol (2010) 0.92
Precalcaneal congenital fibrolipomatous hamartomas: report of 3 additional cases and discussion of the differential diagnosis. Dermatology (2009) 0.91
Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol (1998) 0.91
A tattoo complicated by allergic contact dermatitis and panniculitis. J Eur Acad Dermatol Venereol (2013) 0.91
Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol (2011) 0.90
Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. Dermatology (1992) 0.90
Evidence for activation of the sympathetic nervous system by recombinant human interleukin-1 beta in humans. J Immunother Emphasis Tumor Immunol (1993) 0.90
Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. J Invest Dermatol (1997) 0.89
Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol (1993) 0.89
Cutaneous manifestations in anorexia nervosa. Schweiz Med Wochenschr (2000) 0.89
Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood (1988) 0.88
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol (2001) 0.88
IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol (1999) 0.88
Autoimmune progesterone dermatitis: potential role of cutaneous angiogenin expression? Dermatology (2011) 0.88
Focal palmoplantar keratoderma caused by an autosomal dominant inherited mutation in the desmoglein 1 gene. Dermatology (2006) 0.88
Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol (2005) 0.87
Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol (2013) 0.87
Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol (2001) 0.86
Scabies, boring skin and psyche. A situation report. Dermatology (2009) 0.86
Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol (1995) 0.86
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer (2005) 0.86
Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction. Eur J Immunol (1995) 0.86
Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis? Br J Dermatol (2005) 0.86
Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivo. J Cardiovasc Pharmacol (1990) 0.85
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Ann Oncol (2002) 0.85
IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol (2000) 0.85
Evaluation of the Sysmex R-1000. An automated reticulocyte analyzer. Am J Clin Pathol (1990) 0.85
In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis. Arch Dermatol Res (1993) 0.84
Localized unilateral hyperhidrosis. Dermatology (1992) 0.84
Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest (1997) 0.84
Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis (1999) 0.83
Pyogenic granuloma-like lesions during capecitabine therapy. Br J Dermatol (2002) 0.83
Diagnostic screening of multiple antigen-antibody reactions in a new single assay on nitrocellulose: the line immunobinding assay (LIBA). J Immunol Methods (1989) 0.83
IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Br J Dermatol (2001) 0.83
Clinical controversy on the effect of topical ciclosporin: what is the target site? Dermatology (1992) 0.83
Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene. Dermatology (2008) 0.83
Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia. Br J Dermatol (2005) 0.82
Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro. Clin Immunol Immunopathol (1990) 0.82
Systemic light-chain amyloidosis revealed by progressive nail involvement, diffuse alopecia and sicca syndrome: report of an unusual case with a review of the literature. Dermatology (2014) 0.82
Adult-onset Still's disease with persistent plaques. Br J Dermatol (1999) 0.82
Treatment of primary anetoderma with colchicine. J Am Acad Dermatol (1998) 0.82
[Epidemiology of skin diseases in HIV-infected patients: a prospective cohort study]. Praxis (Bern 1994) (1996) 0.82
High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol (1998) 0.82
Hemidesmosomes: molecular organization and their importance for cell adhesion and disease. Handb Exp Pharmacol (2004) 0.82
Changes in the connective tissue proteins, glycosaminoglycans and calcium in the arteries of the cynomolgus monkey during atherosclerotic induction and regression. Atherosclerosis (1984) 0.81
[Photographic documentation of the effectiveness of 1 mg. oral finasteride in treatment of androgenic alopecia in the man in routine general practice in Switzerland]. Praxis (Bern 1994) (2001) 0.81
Genomic organization of the mouse beta 1 gene: conservation of the beta 1D but not of the beta 1B and beta 1C integrin splice variants. Cell Adhes Commun (1996) 0.81
Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort. Br J Dermatol (2012) 0.81
Interaction of BP180 and alpha6beta4. J Invest Dermatol (1999) 0.81
Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland. BJU Int (2003) 0.81
Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies. J Clin Microbiol (1996) 0.81
Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study. Support Care Cancer (1995) 0.81
Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype. Clin Exp Dermatol (2009) 0.80
Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma. Bone Marrow Transplant (2009) 0.80
Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals. Infection (2008) 0.80
Non-AIDS-associated Kaposi's sarcoma (classical and endemic African types): treatment with low doses of recombinant interferon-alpha. J Invest Dermatol (1990) 0.80
Erosive pustular dermatosis of the leg: report of three cases. Br J Dermatol (2002) 0.80
An unusual form of primary systemic amyloidosis: amyloid elastosis: report of a case treated by haematopoietic cell transplantation. Br J Dermatol (2003) 0.80